{"transactions":[{"id":4072719,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Medical Officer"}}],"security":"Stock Option","published_at":"2018-02-07T23:08:56.000Z","date":"2018-02-05","kind":"grant","acquired":true,"shares":9250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents option of which 1/24th of the shares underlying the option becomes vested and exercisable on March 5, 2018 and an additional 1/24th of the shares underlying the option becomes vested and exercisable each month thereafter."}],"balance_after":9250,"derivative":{"exercise_price":81.49,"expiration_date":"2028-02-05","underlying":"Common Stock","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0001209191-18-008219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919118008219/doc4.xml","form_type":"4"}},{"id":4072718,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-07T23:08:56.000Z","date":"2018-02-06","kind":"tax_withholding","acquired":false,"shares":1014,"price":82.48,"value":83634.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Payment of tax liability by withholding 1,014 shares of Common Stock incident to the vesting of a security issued in accordance with Rule 16b-3, with the balance of the shares (1,636) maintained by the Reporting Person."}],"balance_after":55946,"source":{"system":"sec-edgar","filing":"0001209191-18-008219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919118008219/doc4.xml","form_type":"4"}},{"id":4072717,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-07T23:08:56.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":1113,"price":83.3957,"value":92819.4141,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Sale of 1,113 shares of common stock issued upon vesting of  restricted stock units on February 5, 2018 to cover payroll and withholding taxes, with the balance of the shares (2,087) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in\na Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the\nReporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $81.43 to $84.41. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":54310,"source":{"system":"sec-edgar","filing":"0001209191-18-008219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919118008219/doc4.xml","form_type":"4"}},{"id":4072716,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-07T23:08:56.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":1500,"price":83.0147,"value":124522.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 1,500 shares of common stock issued upon vesting of 3,000 restricted stock units on February 5, 2018 to cover payroll and withholding taxes, with the balance of the shares (1,500) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in\na Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the\nReporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $81.43 to $84.41. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":52223,"source":{"system":"sec-edgar","filing":"0001209191-18-008219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919118008219/doc4.xml","form_type":"4"}},{"id":4097029,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-18T21:12:40.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":1750,"price":79.1423,"value":138499.025,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 1,750 shares of common stock issued upon vesting of 3,500 restricted stock units on January 16, 2018 to cover payroll and withholding taxes, with the balance of the shares (1,750) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in\na Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the\nReporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $76.09 to $82.04. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":50723,"source":{"system":"sec-edgar","filing":"0001209191-18-004246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919118004246/doc4.xml","form_type":"4"}},{"id":4171827,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Non Qualified Stock Option","published_at":"2017-11-06T21:45:56.000Z","date":"2017-11-02","kind":"exercise","acquired":true,"shares":7518,"price":8.65,"value":65030.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted January 10, 2013 and vested monthly over four years."}],"balance_after":62823,"derivative":{"exercise_price":8.65,"expiration_date":"2023-01-10","underlying":"Common Stock","underlying_shares":7518},"source":{"system":"sec-edgar","filing":"0001209191-17-059434","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117059434/doc4.xml","form_type":"4"}},{"id":4171826,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Incentive Stock Option","published_at":"2017-11-06T21:45:56.000Z","date":"2017-11-02","kind":"exercise","acquired":true,"shares":14049,"price":8.66,"value":121664.34,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option granted January 12, 2012 and vested monthly over four years."}],"balance_after":0,"derivative":{"exercise_price":8.66,"expiration_date":"2022-01-12","underlying":"Common Stock","underlying_shares":14049},"source":{"system":"sec-edgar","filing":"0001209191-17-059434","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117059434/doc4.xml","form_type":"4"}},{"id":4171825,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Non Qualified Stock Option","published_at":"2017-11-06T21:45:56.000Z","date":"2017-11-02","kind":"exercise","acquired":true,"shares":31250,"price":8.66,"value":270625.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option granted January 12, 2012 and vested monthly over four years."}],"balance_after":14049,"derivative":{"exercise_price":8.66,"expiration_date":"2022-01-12","underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001209191-17-059434","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117059434/doc4.xml","form_type":"4"}},{"id":4171824,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-11-06T21:45:56.000Z","date":"2017-11-02","kind":"sale","acquired":false,"shares":7518,"price":69.7056,"value":524046.7008,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $68.21 to $71.75. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":48973,"source":{"system":"sec-edgar","filing":"0001209191-17-059434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117059434/doc4.xml","form_type":"4"}},{"id":4171823,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-11-06T21:45:56.000Z","date":"2017-11-02","kind":"exercise","acquired":true,"shares":7518,"price":8.65,"value":65030.7,"ownership":{"direct":true},"balance_after":56491,"source":{"system":"sec-edgar","filing":"0001209191-17-059434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117059434/doc4.xml","form_type":"4"}},{"id":4171822,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-11-06T21:45:56.000Z","date":"2017-11-02","kind":"sale","acquired":false,"shares":45299,"price":69.7056,"value":3157593.9744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $68.21 to $71.75. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":48973,"source":{"system":"sec-edgar","filing":"0001209191-17-059434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117059434/doc4.xml","form_type":"4"}},{"id":4171821,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-11-06T21:45:56.000Z","date":"2017-11-02","kind":"exercise","acquired":true,"shares":45299,"price":8.66,"value":392289.34,"ownership":{"direct":true},"balance_after":94272,"source":{"system":"sec-edgar","filing":"0001209191-17-059434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117059434/doc4.xml","form_type":"4"}},{"id":4195944,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2017-10-03T23:14:31.000Z","date":"2017-10-02","kind":"exercise","acquired":false,"shares":6925,"price":8.65,"value":59901.25,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option granted January 10, 2013 and vested over 4 years."}],"balance_after":70341,"derivative":{"exercise_price":8.65,"expiration_date":"2023-01-10","underlying":"Common Stock","underlying_shares":6925},"source":{"system":"sec-edgar","filing":"0001209191-17-055457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117055457/doc4.xml","form_type":"4"}},{"id":4195943,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-10-03T23:14:31.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":6925,"price":61.04,"value":422702.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $60.40 to $61.93. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":48973,"source":{"system":"sec-edgar","filing":"0001209191-17-055457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117055457/doc4.xml","form_type":"4"}},{"id":4195942,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-10-03T23:14:31.000Z","date":"2017-10-02","kind":"exercise","acquired":true,"shares":6925,"price":8.65,"value":59901.25,"ownership":{"direct":true},"balance_after":55898,"source":{"system":"sec-edgar","filing":"0001209191-17-055457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117055457/doc4.xml","form_type":"4"}},{"id":4215297,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2017-09-07T21:55:57.000Z","date":"2017-09-05","kind":"exercise","acquired":false,"shares":52817,"price":8.66,"value":457395.22,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option granted January 12, 2012 and vested in 36 equal monthly installments."}],"balance_after":45299,"derivative":{"exercise_price":8.66,"expiration_date":"2022-01-12","underlying":"Common Stock","underlying_shares":52817},"source":{"system":"sec-edgar","filing":"0001209191-17-051944","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117051944/doc4.xml","form_type":"4"}},{"id":4215296,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-09-07T21:55:57.000Z","date":"2017-09-05","kind":"sale","acquired":false,"shares":52817,"price":57.5,"value":3036977.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $57.50 to $57.52. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":48973,"source":{"system":"sec-edgar","filing":"0001209191-17-051944","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117051944/doc4.xml","form_type":"4"}},{"id":4215295,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-09-07T21:55:57.000Z","date":"2017-09-05","kind":"exercise","acquired":true,"shares":52817,"price":8.66,"value":457395.22,"ownership":{"direct":true},"balance_after":101790,"source":{"system":"sec-edgar","filing":"0001209191-17-051944","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117051944/doc4.xml","form_type":"4"}},{"id":4248803,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2017-07-31T20:29:55.000Z","date":"2017-07-27","kind":"exercise","acquired":false,"shares":8734,"price":8.65,"value":75549.1,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option granted January 10, 2013 and vested over 4 years."}],"balance_after":77266,"derivative":{"exercise_price":8.65,"expiration_date":"2023-01-10","underlying":"Common Stock","underlying_shares":8734},"source":{"system":"sec-edgar","filing":"0001209191-17-046685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117046685/doc4.xml","form_type":"4"}},{"id":4248802,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-07-31T20:29:55.000Z","date":"2017-07-27","kind":"sale","acquired":false,"shares":8734,"price":50,"value":436700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."}],"balance_after":48973,"source":{"system":"sec-edgar","filing":"0001209191-17-046685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117046685/doc4.xml","form_type":"4"}},{"id":4248801,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-07-31T20:29:55.000Z","date":"2017-07-27","kind":"exercise","acquired":true,"shares":8734,"price":8.65,"value":75549.1,"ownership":{"direct":true},"balance_after":57707,"source":{"system":"sec-edgar","filing":"0001209191-17-046685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117046685/doc4.xml","form_type":"4"}},{"id":4308870,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2017-05-23T20:36:30.000Z","date":"2017-05-18","kind":"exercise","acquired":false,"shares":21884,"price":8.66,"value":189515.44,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted January 12, 2012 and vests in 36 equal monthly installments."}],"balance_after":98116,"derivative":{"exercise_price":8.66,"expiration_date":"2022-01-12","underlying":"Common Stock","underlying_shares":21884},"source":{"system":"sec-edgar","filing":"0001209191-17-034638","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117034638/doc4.xml","form_type":"4"}},{"id":4308869,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Incentive Stock Option","published_at":"2017-05-23T20:36:30.000Z","date":"2017-05-18","kind":"exercise","acquired":false,"shares":24105,"price":5.76,"value":138844.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted August 25, 2011 and vested in 36 equal monthly installments beginning September 25, 2011."}],"balance_after":0,"derivative":{"exercise_price":5.76,"expiration_date":"2021-08-25","underlying":"Common Stock","underlying_shares":24105},"source":{"system":"sec-edgar","filing":"0001209191-17-034638","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117034638/doc4.xml","form_type":"4"}},{"id":4308868,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Non-Qualified Stock Option","published_at":"2017-05-23T20:36:30.000Z","date":"2017-05-18","kind":"exercise","acquired":false,"shares":59645,"price":5.76,"value":343555.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted August 25, 2011 and vested in 36 equal monthly installments beginning September 25, 2011."}],"balance_after":24105,"derivative":{"exercise_price":5.76,"expiration_date":"2021-08-25","underlying":"Common Stock","underlying_shares":59645},"source":{"system":"sec-edgar","filing":"0001209191-17-034638","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117034638/doc4.xml","form_type":"4"}},{"id":4308867,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-05-23T20:36:30.000Z","date":"2017-05-18","kind":"sale","acquired":false,"shares":105634,"price":53.32,"value":5632404.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $52.27 to $53.69. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":48973,"source":{"system":"sec-edgar","filing":"0001209191-17-034638","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117034638/doc4.xml","form_type":"4"}},{"id":4308866,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-05-23T20:36:30.000Z","date":"2017-05-18","kind":"exercise","acquired":true,"shares":21884,"price":8.66,"value":189515.44,"ownership":{"direct":true},"balance_after":154607,"source":{"system":"sec-edgar","filing":"0001209191-17-034638","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117034638/doc4.xml","form_type":"4"}},{"id":4308865,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-05-23T20:36:30.000Z","date":"2017-05-18","kind":"exercise","acquired":true,"shares":24105,"price":5.76,"value":138844.8,"ownership":{"direct":true},"balance_after":132723,"source":{"system":"sec-edgar","filing":"0001209191-17-034638","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117034638/doc4.xml","form_type":"4"}},{"id":4308864,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-05-23T20:36:30.000Z","date":"2017-05-18","kind":"exercise","acquired":true,"shares":59645,"price":5.76,"value":343555.2,"ownership":{"direct":true},"balance_after":108618,"source":{"system":"sec-edgar","filing":"0001209191-17-034638","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117034638/doc4.xml","form_type":"4"}},{"id":4352932,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-04-13T20:56:36.000Z","date":"2017-04-12","kind":"sale","acquired":false,"shares":204,"price":51.23,"value":10450.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 13,065 shares of common stock issued upon vesting of 25,000 performance restricted stock units on April 11, 2017 to cover withholding taxes, with the balance of the shares (11,935) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $51.19 to $51.25. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":48973,"source":{"system":"sec-edgar","filing":"0001209191-17-026884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117026884/doc4.xml","form_type":"4"}},{"id":4352931,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-04-13T20:56:36.000Z","date":"2017-04-12","kind":"sale","acquired":false,"shares":12861,"price":50.41,"value":648323.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 13,065 shares of common stock issued upon vesting of 25,000 performance restricted stock units on April 11, 2017 to cover withholding taxes, with the balance of the shares (11,935) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $50.20 to $50.73. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":49177,"source":{"system":"sec-edgar","filing":"0001209191-17-026884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117026884/doc4.xml","form_type":"4"}},{"id":4462326,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Option","published_at":"2017-02-09T00:40:45.000Z","date":"2017-02-06","kind":"grant","acquired":true,"shares":10600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Neurocrine Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 6, 2018, February 6, 2019, February 6, 2020, and February 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 6, 2018, February 6, 2019, February 6, 2020, and February 6, 2021."}],"balance_after":10600,"derivative":{"underlying":"Common Stock","underlying_shares":10600},"source":{"system":"sec-edgar","filing":"0001209191-17-008912","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117008912/doc4.xml","form_type":"4"}},{"id":4462325,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2017-02-09T00:40:45.000Z","date":"2017-02-06","kind":"grant","acquired":true,"shares":76800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 6, 2017 and an additional 1/48th of the shares underlying the option becomes vested and excercisable each month thereafter."}],"balance_after":76800,"derivative":{"exercise_price":43.24,"expiration_date":"2027-02-06","underlying":"Common Stock","underlying_shares":76800},"source":{"system":"sec-edgar","filing":"0001209191-17-008912","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117008912/doc4.xml","form_type":"4"}},{"id":4462324,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-02-09T00:40:45.000Z","date":"2017-02-06","kind":"sale","acquired":false,"shares":1206,"price":43.17,"value":52063.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 1206 shares of common stock issued upon vesting of 3200 restricted stock units to cover withholding taxes with the balance of the shares (1994) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $42.91 to $43.46. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":37038,"source":{"system":"sec-edgar","filing":"0001209191-17-008912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117008912/doc4.xml","form_type":"4"}},{"id":4466882,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-02-07T00:16:26.000Z","date":"2017-02-03","kind":"sale","acquired":false,"shares":1500,"price":42.5,"value":63750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 1,500 shares of common stock issued upon vesting of 3,000 restricted stock units on February 3, 2017 to cover payroll and withholding taxes, with the balance of the shares (1,500) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $41.80 to $43.29. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":35044,"source":{"system":"sec-edgar","filing":"0001209191-17-008131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117008131/doc4.xml","form_type":"4"}},{"id":4488886,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-01-18T23:41:00.000Z","date":"2017-01-17","kind":"sale","acquired":false,"shares":1750,"price":40.66,"value":71155.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 1,750 shares of common stock issued upon vesting of 3,500 restricted stock units on January 17, 2017 to cover payroll and withholding taxes, with the balance of the shares (1,750) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $39.91 to $41.59. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":33544,"source":{"system":"sec-edgar","filing":"0001209191-17-004301","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117004301/doc4.xml","form_type":"4"}},{"id":4492572,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-01-13T00:02:46.000Z","date":"2017-01-10","kind":"sale","acquired":false,"shares":1750,"price":43.35,"value":75862.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 1,750 shares of common stock issued upon vesting of 3,500 restricted stock units on January 10, 2017 to cover payroll and withholding taxes, with the balance of the shares (1,750) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $42.50 to $45.49. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":31794,"source":{"system":"sec-edgar","filing":"0001209191-17-003588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117003588/doc4.xml","form_type":"4"}},{"id":4553603,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":169686,"kind":"person","name":"OBrien Christopher Flint","position":1,"cik":"0001343124","reported_name":"OBrien Christopher Flint","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-11-16T20:52:48.000Z","date":"2016-11-15","kind":"sale","acquired":false,"shares":25000,"price":52.84,"value":1321000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $52.29 to $54.09. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":30044,"source":{"system":"sec-edgar","filing":"0001209191-16-150474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919116150474/doc4.xml","form_type":"4"}}]}